Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Evp & Cfo
-
Issuer Symbol
-
RPRX on Nasdaq
Terrance P. Coyne - trading volume in the past year for Royalty Pharma plc
Holdings reported by Terrance P. Coyne for Royalty Pharma plc
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| LP interests in RPI US Partners 2019, LP |
483,942 |
$173,444,812 |
$358.40 |
06 Aug 2025 |
By TPC RP, LLC |
Class A Ordinary Shares |
4,839,420 |
| LP interests in RPI US Partners 2019, LP |
117,526 |
$42,121,318 |
$358.40 |
06 Aug 2025 |
By TPC RP 2021, LLC |
Class A Ordinary Shares |
1,175,260 |
| LP interests in RPI US Partners 2019, LP |
43,350 |
$15,536,640 |
$358.40 |
08 Aug 2025 |
By TPC ICAI, LLC |
Class A Ordinary Shares |
433,500 |
| Class A Ordinary Shares |
98,748 |
$4,642,587 |
$47.01 |
02 Mar 2026 |
By TPC RP 2021, LLC |
|
|
| Class A Ordinary Shares |
45,761 |
$2,151,421 |
$47.01 |
02 Mar 2026 |
TPC RP EPA1 LLC |
|
|
| Class A Ordinary Shares |
24,170 |
$1,023,841 |
$42.36 |
02 Mar 2026 |
By Spouse's IRA |
|
|
| Class A Ordinary Shares |
23,270 |
$985,717 |
$42.36 |
02 Mar 2026 |
By IRA |
|
|
| Class A Ordinary Shares |
1,500 |
$63,540 |
$42.36 |
02 Mar 2026 |
Direct |
|
|
| Class A Ordinary Shares |
1,450 |
$61,422 |
$42.36 |
02 Mar 2026 |
By Spouse |
|
|
| Class E Ordinary Shares |
1,807,277 |
|
|
16 May 2025 |
Indirect |
Class A Ordinary Shares |
|
Transactions reported by Terrance P. Coyne for Royalty Pharma plc
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.